| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 6 |
| 1 | ALLOPURINOL | 5 |
| 2 | VEDOLIZUMAB | 5 |
| 3 | FLUDARABINE PHOSPHATE | 3 |
| 4 | RITUXIMAB | 3 |
| 5 | ALEMTUZUMAB | 2 |
| 6 | AXICABTAGENE CILOLEUCEL | 2 |
| 7 | METHOTREXATE SODIUM | 2 |
| 8 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 |
| 9 | ADALIMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 1 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 2 | AXICABTAGENE CILOLEUCEL | 2 | 0.0002 |
| 3 | VINORELBINE | 1 | 0.0001 |
| 4 | ALEMTUZUMAB | 2 | 0.0001 |
| 5 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| 6 | BLINATUMOMAB | 1 | 0.0001 |
| 7 | FLUDARABINE PHOSPHATE | 3 | 0.0001 |
| 8 | AZATHIOPRINE | 6 | 0.0001 |
| 9 | BICALUTAMIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 3 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | General Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |